Mark R. Bray
Impact in
- Cell Biology top 2%
- Microtubule and mitosis dynamics
- Oncology top 5%
- Cancer-related Molecular Pathways
Papers in
- Cell Biology 29
- Microtubule and mitosis dynamics 29
-
- Protein Degradation and Inhibitors 7
- Co-authors
- Tak W. Mak (20 shared papers)Jacqueline M. Mason (7 shared papers)Graham C. Fletcher (22 shared papers)Bryan E. Snow (3 shared papers)Anthony J. Clarke (5 shared papers)Kelsie L. Thu (4 shared papers)Heiko Blaser (1 shared paper)Carmen Dominguez‐Brauer (1 shared paper)
- Journals
- Blood (12 papers)Clinical Cancer Research (5 papers)Molecular Cancer Therapeutics (5 papers)Cancer Research (4 papers)Proceedings of the National Academy of Sciences (3 papers)
- Partner nations
- CanadaUnited StatesHong Kong
In The Last Decade
Mark R. Bray
64 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 111
- Cell Biology 728
- Oncology 754
- Biotechnology 205
- Molecular Biology 1.6k
- Cancer Research 345
Countries citing papers authored by Mark R. Bray
This map shows the geographic impact of Mark R. Bray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Bray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Bray more than expected).
Fields of papers citing papers by Mark R. Bray
This network shows the impact of papers produced by Mark R. Bray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Bray. The network helps show where Mark R. Bray may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark R. Bray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 473 | |
| 2 | 2015 | 365 | |
| 3 | Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. | 2003 | 353 |
| 4 | 2014 | 142 | |
| 5 | 2000 | 124 | |
| 6 | 2010 | 109 | |
| 7 | 2017 | 92 | |
| 8 | 1999 | 78 | |
| 9 | 1997 | 70 | |
| 10 | 2010 | 57 | |
| 11 | 1992 | 47 | |
| 12 | 1996 | 46 | |
| 13 | 2019 | 45 | |
| 14 | 2016 | 44 | |
| 15 | 2012 | 42 | |
| 16 | 2010 | 41 | |
| 17 | 2012 | 39 | |
| 18 | 2012 | 39 | |
| 19 | 2010 | 39 | |
| 20 | 2022 | 38 |
About Mark R. Bray
Mark R. Bray is a scholar working on Cell Biology, Molecular Biology, Oncology, Cancer Research and Hematology, having authored 65 papers that have together received 2.7k indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (29 papers), Cancer Genomics and Diagnostics (12 papers), Cancer-related Molecular Pathways (11 papers), Acute Myeloid Leukemia Research (10 papers), Protein Degradation and Inhibitors (7 papers), Multiple Myeloma Research and Treatments (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Cell Biology (728 citations), Oncology (754 citations), Biotechnology (205 citations), Molecular Biology (1.6k citations) and Cancer Research (345 citations). Mark R. Bray has collaborated with scholars based in Canada, United States and Hong Kong. Frequent co-authors include Tak W. Mak, Jacqueline M. Mason, Graham C. Fletcher, Bryan E. Snow, Anthony J. Clarke, Kelsie L. Thu, Heiko Blaser, Carmen Dominguez‐Brauer, Robert J. Deeth and Dennis J. Slamon. Their work appears in journals such as Blood, Clinical Cancer Research, Molecular Cancer Therapeutics, Cancer Research and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.